Sleep Apnea Devices Market Size (2024 - 2029)

The sleep apnea devices market is projected to experience significant growth over the forecast period, driven by increasing incidences of sleep apnea, a rising geriatric population, and heightened awareness in developing countries. The market's expansion is further supported by the introduction of innovative products by manufacturers to meet growing demand. Despite these positive trends, the high cost of CPAP machines poses a challenge to market growth. The impact of the COVID-19 pandemic on sleep disorders and the recognition of obstructive sleep apnea as a comorbidity risk factor are also influencing market dynamics.

Market Size of Sleep Apnea Devices Industry

Sleep Apnea Devices Market  Summary
Study Period 2021 - 2029
Market Size (2024) USD 8.20 Billion
Market Size (2029) USD 11.68 Billion
CAGR (2024 - 2029) 7.33 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Sleep Apnea Devices Market  Major Players

*Disclaimer: Major Players sorted in no particular order

Sleep Apnea Devices Market Analysis

The Sleep Apnea Devices Market size is estimated at USD 8.20 billion in 2024, and is expected to reach USD 11.68 billion by 2029, growing at a CAGR of 7.33% during the forecast period (2024-2029).

The COVID-19 pandemic is expected to have a significant impact on the sleep apnea devices market. According to a study published in January 2021 in the BMJ Open Respiratory Research, patients with obstructive sleep apnea (OSA) had a 2.93 times higher risk to be hospitalized when affected by COVID-19 than non-OSA individuals. The study also suggested that in the assessment of patients who were suspected or confirmed with COVID-19 infection, obstructive sleep apnea should be recognized as one of the comorbidity risk factors for developing a severe form of the disease. As per the article published by the Sleep Foundation Organization in March 2022, COVID-19 altered and interrupted sleep patterns in a variety of ways. The article further stated that studies have found that the prevalence of insomnia symptoms among adults, children, and adolescents had increased noticeably, and almost 40% of people report having trouble sleeping. This increase in sleep disorders even post-pandemic is expected to have an impact on the sleep apnea market in the years to come.

The major factors driving the market include the increasing incidences of sleep apnea, an increase in the geriatric population, an increase in the prevalence of obesity and hypertension, and increasing awareness among the patient population in developing countries. Aging is a major factor driving the market growth for sleep apnea devices. The elderly are the most at risk for developing this disorder. According to the World Population Prospects 2022, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. By 2050, the number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12.

Also, the increasing launches by manufacturers to meet the growing demand for innovative products are expected to drive market growth. For instance, in August 2021, ResMed unveiled a new sleep apnea machine amid a scramble to fill the void left by Philips' CPAP recall. Similarly, in February 2021, GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea launched its new product O2Vent Optima, a highly effective and more convenient alternative to CPAP therapy.

Furthermore, it also reported that sleep disorders represent some of the most challenging medical conditions and affect 1 out of 3 people at some stage of their lives. Sleep apnea is a serious and life-threatening sleep illness that usually goes undiagnosed and untreated. However, various government initiatives are helping patients who suffer from OSA. For instance, in the United States, the American Sleep Apnea Association (ASAA) which is a non-profit organization that promotes awareness regarding sleep apnea, works for continuing improvements in treatments, and advocates for the interests of sleep apnea patients.

Thus, the above-mentioned factors are boosting the market's growth. However, the high cost of CPAP Machines is expected to hinder the growth of the market.

Sleep Apnea Devices Industry Segmentation

As per the scope, sleep apnea is a serious sleep disorder in which breathing repeatedly fluctuates. There are three main types of sleep apnea, obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome.

The sleep apnea devices market is segmented by Diagnostic Devices (Polysomnography Devices (PSG), Pulse Oximeters, and Actigraphy Devices), Therapeutic Devices (Positive Airway Pressure (PAP) Devices, Oxygen Devices, Oral Appliances, Adaptive Servo-Ventilation (ASV) Devices, and Masks and Accessories), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above-mentioned segments.

By Diagnostic Devices
Polysomnography Devices (PSG)
Pulse Oximeters
Actigraphy Devices
By Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Continuous Positive Airway Pressure (CPAP) Devices
Bi-level Positive Airway Pressure (BiPAP) Devices
Oxygen Devices
Oxygen Concentrators
Portable Oxygen Concentrators
Liquid Portable Oxygen
Oral Appliances
Adaptive Servo Ventilation (ASV) Devices
Masks and Accessories
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Sleep Apnea Devices Market Size Summary

The sleep apnea devices market is poised for significant growth, driven by an increasing prevalence of sleep apnea, a rising geriatric population, and heightened awareness in developing regions. The market is experiencing a surge in demand due to the growing incidence of obesity and hypertension, which are closely linked to sleep apnea. The COVID-19 pandemic has further influenced the market, as it highlighted the risks associated with obstructive sleep apnea (OSA) in COVID-19 patients, leading to increased awareness and diagnosis. The market is also witnessing a wave of innovation, with manufacturers launching new products to meet the evolving needs of patients. This includes advancements in devices such as CPAP machines and oral appliances, which are becoming more accessible and convenient for users. Government initiatives and non-profit organizations are playing a crucial role in promoting awareness and improving treatment options, thereby supporting market expansion.

North America currently leads the sleep apnea devices market, driven by a high prevalence of sleep apnea and obesity, along with technological advancements and increased product launches. The region's market growth is further supported by the impact of COVID-19, which has exacerbated sleep disorders among the population. The competitive landscape is characterized by the presence of major players like ResMed, Fisher & Paykel Healthcare Limited, and Invacare Corporation, who are continuously innovating to maintain their market positions. The market is also seeing increased participation from mid-size and small-scale companies, which are introducing new devices at competitive prices. Collaborative efforts, such as partnerships and product launches, are expected to further propel market growth, as companies strive to address the diverse needs of sleep apnea patients globally.

Explore More

Sleep Apnea Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Awareness Among the Patient Population in the Developing Countries

      2. 1.2.2 Increase in Prevalence of Obesity and Hypertension

      3. 1.2.3 Upcoming Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Cpap Machines

    4. 1.4 Industry Attractiveness- Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Diagnostic Devices

      1. 2.1.1 Polysomnography Devices (PSG)

      2. 2.1.2 Pulse Oximeters

      3. 2.1.3 Actigraphy Devices

    2. 2.2 By Therapeutic Devices

      1. 2.2.1 Positive Airway Pressure (PAP) Devices

        1. 2.2.1.1 Continuous Positive Airway Pressure (CPAP) Devices

        2. 2.2.1.2 Bi-level Positive Airway Pressure (BiPAP) Devices

      2. 2.2.2 Oxygen Devices

        1. 2.2.2.1 Oxygen Concentrators

        2. 2.2.2.2 Portable Oxygen Concentrators

        3. 2.2.2.3 Liquid Portable Oxygen

      3. 2.2.3 Oral Appliances

      4. 2.2.4 Adaptive Servo Ventilation (ASV) Devices

      5. 2.2.5 Masks and Accessories

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Sleep Apnea Devices Market Size FAQs

The Sleep Apnea Devices Market size is expected to reach USD 8.20 billion in 2024 and grow at a CAGR of 7.33% to reach USD 11.68 billion by 2029.

In 2024, the Sleep Apnea Devices Market size is expected to reach USD 8.20 billion.

Sleep Apnea Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)